Introduction
Cell motility is important for cancer dissemination (Woodhouse et al., 1997) . Motile cells extend¯at, organelle-free membrane processes formed by actin polymerization called lamellipodia (Mitchison and Cramer, 1996) . Forward extension of a lamellipodium and retraction of the trailing edge results in translocation of the cell body (Lauenberger and Horwitz, 1996) . A number of growth factors, including insulinlike growth factor-I (IGF-I) , can regulate cell motility. Our laboratory is characterizing the mechanisms of IGF-I mediated motility in neuroblastoma (NBL) cells. NBL frequently disseminates through bone tissue, becoming refractory to conventional therapies (Tanabe et al., 1995) . As bone produces IGF-I (Mohan and Baylink, 1991) , IGF-I may be important for regulating the ability of NBL cells to invade bone.
IGF-I activates the type I IGF receptor (IGF-IR). Tyrosine autophosphorylation of the beta subunits leads to the recruitment and phosphorylation of the insulin receptor substrates (IRS-1 through -4). Phosphorylated IRS recruits the Shc and the Grb2-Sos complex to activate the mitogen-activated protein kinase (MAPK) pathway, as well as the p85 subunit of phosphatidylinositol 3-kinase (PI3-K), activating its p110 catalytic subunit (White, 1998; Myers et al., 1994) . The MAPK pathway is important for IGFstimulated neurite elaboration in human SH-SY5Y NBL cells , while IGF activation of PI3-K leads to SH-SY5Y membrane ruing (Kim and Feldman, 1998) and prevention of SHEP NBL cell apoptosis (van Golen and Feldman, 2000) .
PI3-K may be important for regulating cell motility. Migration of smooth muscle cells in response to IGF-I depends upon PI3-K function (Imai and Clemmons, 1999) . The PI3-K pathway is implicated in the functioning of rac, which regulates actin cytoskeletal architecture (Hall, 1998) . Rac stimulates the formation of lamellipodia. Some investigations have demonstrated that PI3-K-dependent cytoskelatal changes are blocked by dominant negative rac, and rues caused by constitutively active rac are not blocked by inhibitors of PI3-K (Hawkins et al., 1995; Ma et al., 1998; Hooshmand-Rad et al., 1997; Kotani et al., 1995) . Blocking MAPK activation causes partial inhibition of IGF-I stimulated migration in smooth muscle cells (Imai and Clemmons, 1999) and keratinocytes (Zeigler et al., 1999) . The potential downstream targets of MAPK signaling relevant to the regulation of cell motility remain unknown.
Considering the numerous eects IGF-I has on NBL cells and its potential role in NBL invasiveness, we characterized the eect of IGF-I on the motility of SH-SY5Y and SHEP NBL cells. To assess the ability of IGF-I to promote a motile morphology in SH-SY5Y cells, a video assay that quanti®es the amount of shape change exhibited by the cells over a period of time was used, as well as measurement of the size of lamellipodia elaborated in response to IGF-I. An assay in which moving cells etch out a visible path on coverslips coated with gold particles was used to quantify the eect of IGF-I on cell motility. Pharmacological and molecular inhibitors of the PI3-K and MAPK pathways were used to address the relative involvement of these pathways in the mechanism of IGF-I mediated motility. Finally, the motility of SHEP and SH-SY5Y cells, which respectively express IRS-1 and IRS-2, was compared to determine if the two IRS isoforms have dierent roles in transducing the signal for cell motility.
Results

IGF-I stimulates immediate, dynamic changes in SH-SY5Y cell morphology
Time-lapse video microscopy was used to assess the ability of IGF-I to change quiescent SH-SY5Y cells to a motile morphology. Serum-starved SH-SY5Y cells were digitally photographed at 30 s intervals for 20 min. Then, 1 nM IGF-I was added to the cultures, followed by additional image collection at 30 s intervals for 20 ± 40 min. Figure 1a shows selected images from one experiment. Prior to stimulation, the cells show a number of morphologies, but are generally broad and¯attened with few membrane extensions reminiscent of lamellipodia. The cells show littlē uctuation in morphology prior to stimulation. Within minutes of stimulation with 1 nM IGF-I, the cells begin to dynamically extend and retract membranous processes. Numerous dark membrane rues are seen along the cell margin. Some cells quickly extend lamellipodia. These changes in morphology are consistent with the acquisition of a motile phenotype.
However, despite the few cells in some experiments that begin to translocate, the majority of cells do not exhibit frank motilty during the ®rst 40 min poststimulation, but rather profound shape changes.
To quantify the eect of IGF-I on SH-SY5Y morphology, a dierence image analysis technique was used (Shelden and Feldman, 2000) . Each sequential frame in the time-lapse movie was digitally subtracted from the previous image, revealing the area of cell shape that changed between the two frames. Individual, non-dividing cells that did not contact other cells were selected from at least three separately performed experiments. For each cell, the area of shape change between each pair of images was plotted sequentially versus time. (A representative plot for one cell is shown in Figure 2a .) The area under the curve (AUC) was measured for the 20 min before stimulation, and the two 20 min intervals after stimulation. The AUCs collected for 6 ± 12 cells were averaged to produce the mean shape change per cell for each 20 min time interval. Figure 2b (black bars) shows the fold increase in shape change over the unstimulated baseline mean for the ®rst and second 20 min intervals following stimulation with 1 nM IGF-I. IGF-I causes a 2 ± 3-fold increase in dynamic cell shape change.
To determine if IGF-I signals through the IGF-IR to cause cells to acquire a motile morphology, activation of the IGF-IR by IGF-I was blocked with the aIR-3 antibody. Serum-starved cultures were treated with 1 mg/ml aIR-3 1 h before time-lapse imaging, and then imaged for 20 min before and 40 min following 1 nM IGF-I addition. Control cells were not treated with the antibody to con®rm activity of the IGF-I. Prior to stimulation, the antibody-treated cells resembled the 
IGF-I induces the formation of larger lamellipodia
To assess the eect of IGF-I on lamellipodium size, serum-starved SH-SY5Y cells plated on glass coverslips were stimulated for 10 min with 1 nM IGF-I and then ®xed. Digital images of the cells were collected as described in Materials and methods. Figure 3a shows a representative ®eld of cells stimulated with 1 nM IGF-I. The areas of 105 lamellipodia from each condition (untreated, or treated with 1 nM IGF-I) were measured and averaged (Figure 3b ). IGF-I increased the size of the lamellipodia by about 60% (P50.001).
In similar experiments, serum-staved SH-SY5Ys were pre-treated with 10 mM PD98059 or LY290042, to block signaling through the MAP Kinase and PI3-K pathways, respectively (Figure 3b) . In a previous qualitative assessment of lamellipodia, LY294002, but not PD98059, altered lamellipodia formation (Kim and Feldman, 1998) . In the current quantitative assay, IGF-I was still able to stimulate larger lamellipodia in the presence of either inhibitor, even at higher doses of inhibitor (50 mM, data not shown). However, when 
SH-SY5Y cell motility is enhanced by IGF-I
The long-term eects of IGF-I on cell motility was measured using the phagokinetic track assay (Albrecht-Buehler, 1977) . In this assay, SH-SY5Y cells are plated on coverslips coated with ®ne gold particles. As the cells move, the gold particles are Phosphorylation of IRS-I in response to IGF-I is also seen in vector-transfected SHEP cells (data not shown). While SHEP and SH-SY5Y cells dier in IRS-I isoform expression, both cell lines express similar levels of Shc (data not shown). (b) SHEP cell motility was assessed using the gold-particle coverslip assay. Bars represent motility as a percentage of unstimulated, untrasfected SHEP cells (562.39+24.30 pixels). SHEPs treated with 1 nM IGF-I show increased motility (*P50.0001). SHEPs expressing high levels of IGF-IR-I have the same degree of baseline motility as unstimulated, untransfected SHEPs, and also increase motility in response to IGF-I (*P50.0001). n=150 cells for each condition Figure 4 The motility of SH-SY5Y cells is increased by IGF-I. Cells were plated on coverslips coated with gold particles, treated with or without IGF-I for 6 or 12 h, then ®xed and mounted. (a) Example of tracks left in the gold-particle coated surface by migrating cells. Arrow indicates the gold internalized in the cell body. Arrowhead points to the area over which the cell moved during the incubation. (b) Average increase in track area in response to 1 nM IGF-I treatment for 6 and 12 h. *P50.0001 in comparison to unstimulated controls for both conditions. (c) Eect of dierent concentrations of IGF-I on SH-SY5Y motility. **P50.001 for each condition, in comparison to unstimulated controls. For all conditions, n=150 cells internalized, leaving a cleared area representing the cell track. Figure 4a shows an example of ®xed cells surrounded by track areas cleared of gold particles. Figure 4b shows the eect of 1 nM IGF-I on SH-SY5Y motility, with cells being ®xed at 6 and 12 h after stimulation with IGF-I. A 50% increase in motility is observed in response to 1 nM IGF-I at 6 h, increasing to 80% more motility 12 h poststimulation. The motility response lags several hours behind initial exposure to IGF-I. Increased motility is not observed in cells exposed to IGF-I for 1 or 2 h (data not shown). The eect of dierent concentrations of IGF-I is depicted in Figure 4c . Both 0.1 and 1.0 nM IGF-I increase motility by over 60% at 12 h, but 10 nM IGF-I increases motility by only 30%. This is consistent with observations that 10 nM IGF-I promotes the dierentiation of SH-SY5Y cells.
IRS isoform and IGF-IR expression in motility signaling
The SHEP human NBL cell line is less invasive in vivo than the SH-SY5Y line (Biedler et al., 1988) . Recent work in breast cancer cells suggests an association between signaling through IRS-2 and increased invasiveness in response to IGF-I (Jackson et al., 1999) . SH-SY5Y cells utilize IRS-2, instead of IRS-1, for IGF-I signaling (Kim et al., 1998a,b) . The treatment of SH-SY5Y cells with 10 nM IGF-I for 5 min induces a tyrosine phosphorylation of IRS-2 with no detectable phosphorylation of IRS-1 ( Figure  5a , upper panel). In contrast, 10 nM IGF-I induces a strong tyrosine phosphorylation of IRS-1 in SHEP cells, and very weak phosphorylation of IRS-2 ( Figure  5a, upper panel) .
After tyrosine phosphorylation, IRS-1 or IRS-2 can bind with various downstream signaling molecules including the p85 subunit of PI 3-K (Myers and White, 1996) . In SH-SY5Y cells, IGF-I treatment induces the association of IRS-2 with PI 3-K (Kim et al., 1998a,b) . Anti-p85pan immunoblotting from anti-IRS-1 or anti-IRS-2 immunoprecipitates shows the association between IRS-2 and p85, but not between IRS-1 and p85, after IGF-I stimulation in SH-SY5Y cells (Figure 5a , lower panel). In parallel with IRS tyrosine phosphorylations, the stimulation of SHEP/ IGF-IR cells with 10 nM IGF-I induced an association of p85 with IRS-1 but not with IRS-2 (Figure 5a , lower panel). These results show that SH-SY5Y and SHEP/IGF-IR cells utilize unique signaling patterns upon IGF-I stimulation.
The gold particle motility assay was used to determine if there was a dierence in motility between the two cell lines. Despite signaling exclusively through IRS-1, SHEP cells increase motility in response to IGF-I (Figure 5b) . After 6 h, 1 nM IGF-I increased SHEP motility by almost 60%. Thus, the relative increase in motility stimulated by IGF-I is the same between the two cell lines. Yet, the absolute magnitude of cell motility diers. SHEP cells stimulated with IGF-I are about as motile as unstimulated SH-SY5Y cells (941.77+33.37 pixels for unstimulated SH-SY5Y cells vs 875.87+34.44 pixels for stimulated SHEP cells).
In contrast to SH-SY5Y cells, SHEP cells express very little IGF-IR (Singleton et al., 1996) . Our results suggest that the IGF-IR receptor is required for the ability of IGF-I to induce a motile phenotype. SHEP cells were stably transfected to express high levels of the IGF-IR (Singleton et al., 1996) . Even though increased IGF-IR expression enhanced the ability of SHEP cells to resist apoptosis (Yamamoto et al., 1993) , increased expression of IGF-IR did not signi®cantly alter the magnitude of IGF-I-mediated motility (Figure 5b ). 
IGF-I-induced motility is dependent upon PI3-K and MAPK signaling mechanisms
The involvement of PI3-K in IGF-mediated motility was investigated by pre-treating SH-SY5Y cells on gold coverslips with the PI3-K inhibitor LY294002 (10 mM), 1 h prior to stimulation with 1 nM IGF-I. Previous work from our laboratory showed that 10 mM LY294002 was sucient to block PI3-K activity in this cell line (data not shown). After 6 h, LY294002 had no eect on baseline SH-SY5Y motility. Yet, LY294002 decreased the ability of IGF-I to stimulate the motility of SH-SY5Y cells by about 50% (Figure  6a ). This argues that functional PI3-K is a required component of the signaling pathway that orchestrates IGF-I-mediated motility.
PTEN is a tumor suppressor that dephosphorylates the 3' phosphoinositides synthesized by PI3-K (Maehama and Dixon, 1998) , and thus antagonizes PI3-K signaling. Wild type PTEN was overexpressed in SHEP cells. Expression was con®rmed by Western blot (van Golen et al., 2001) . SHEP cells expressing wild-type PTEN showed a decreased motility response to IGF-I (by about 50%) (Figure 6b ). Again this suggests that PI3-K signaling is required for IGF-I stimulated motility.
As IGF-I also stimulates the MAPK pathway, SH-SY5Y cells were treated with 10 mM PD98059, an inhibitor of MEK that prevents IGF-I-mediated increases in ERK activity in SH-SY5Y cells . At 6 h, PD98059 alone did not aect baseline SH-SY5Y motility, but it did inhibit IGF-Iinduced motility by about 40% (Figure 6a ). As there is evidence for crosstalk between MAPK and PI3-K signaling pathways (Kim et al., 1998b) , SH-SY5Y cells were treated with 10 mM concentrations of both LY294002 and PD98059 simultaneously. Figure 6a shows that combining both inhibitors has no greater an eect than using LY294002 alone. Thus MAPK and PI3-K do not appear to regulate motility through completely separate pathways.
Discussion
The dissemination of NBL throughout bone tissue (rich in IGFs) poses a major obstacle to treating the disease (Tanabe et al., 1995) . Here we examine the ability of IGF-I to promote morphological changes and motility in human SH-SY5Y NBL cells, as well as initially characterize the signaling mechanisms utilized by IGF-I to enact these changes.
Rapidly following IGF-I administration, SH-SY5Y cells increase dynamic changes in morphology by over twofold, extending and retracting small membrane processes and lamellipodia. Previously, a 30 min exposure to IGF-I was found to stimulate SH-SY5Y cells to produce lamellipodia with a brush-like actin meshwork . These results indicate that IGF-I can promote SH-SY5Y cells to exhibit a morphology characteristic of a motile cell.
The morphological changes are inhibited when the cells are pre-exposed to an antibody that prevents activation of the IGF-IR, indicating the requirement for activation of this receptor to initiate the signaling mechanisms that lead to these changes.
The rapid onset of these dynamic changes parallels the time course of PI3-K activation following IGF-I administration in SH-SY5Y cells. The PI3-K inhibitors wortmannin and LY294002 prevent IGF-I mediated cytoskeletal reorganization and lamellipodium formation (Kim and Feldman, 1998) . Whereas the association of PI3-K with IRS-2 attenuates within 10 min of IGF-I administration (Kim et al., 1998b) , SH-SY5Y cells continue to change morphology up to (Figure 2 ) and beyond (data not shown) 40 min, the ®nal time point quanti®ed in the shape change assay. This suggests that if PI3-K were mediating these eects, then either downstream targets of PI3-K remain activated long after PI3-K activity is attenuated, or other parallel signaling pathways have a role in the cell morphology eect.
The average area of lamellipodia formed by SH-SY5Y cells is increased by IGF-I. Blocking either the MAPK or the PI3-K pathways has no signi®cant eect on this response, but blocking both pathways simultaneously decreases lamellipodium size. It would appear then that signaling through both the MAPK and PI3-K pathways contributes to the regulation of lamellipodium extension. Whether this aect can be attributed to crosstalk between the two pathways, or the activation of distinct targets important for lamellipodium formation is unknown.
The time-lapse microscopy videos indicated that a subset of SH-SY5Y cells stimulated with IGF-I become motile within the ®rst few hours following IGF-I administration. The motility stimulated by IGF-I was quanti®ed by measuring the track areas of SH-SY5Y cells after they moved over a gold particle-coated surface for 6 or 12 h. At concentrations of 0.1 and 1 nM, IGF-I increased SH-SY5Y motility by about 50% at 6 h ( Figure 4c) . A higher concentration of IGF-I, 10 nM, caused somewhat less motility. This concurs with several previous reports. Rat osteoblast migration was stimulated most eectively by 0.1 ng/ml IGF-I, and not at all by 100 ng/ml (Panagakos, 1993) . MCF-7 cells exhibited maximum responsiveness to 1 ng/ml IGF-I, and less motility as the concentration increased to 100 ng/ml (Mira et al., 1999) . A possible explanation for this eect in SH-SY5Y cells is that higher concentrations of IGF-I promote dierentiation, as opposed to migration. Increasing doses of IGF-I cause increased GAP-43 expression and neurite growth in SH-SY5Y cells (Sumantran and Feldman, 1993; Kim et al., 1997) .
The eect of IGF-I on SH-SY5Y motility could be attenuated by 50% when the cells were pretreated with LY294002, an inhibitor of PI3-K (Figure 6a) . Additionally, overexpression of PTEN, which inactivates the phosphoinositide products of PI3-K, inhibits IGF-I stimulated motility in SHEP cells by about 50% (Figure 6b ). This would suggest that PI3-K is a critical component of the signaling mechanism activated by IGF-I that regulates cell motility. Blocking PI3-K function leads to decreased IGF-I-mediated motility in other cell lines, including smooth muscle (Imai and Clemmons 1999) and Schwann cells (Cheng et al., 2000) . PI3-K seems a likely candidate for a role in orchestrating cell motility processes, as it is linked to the regulation of rac. PI3-K is required for the ability of PDGF to increase the GTP-bound state of rac (Hawkins et al., 1995) . Further, while both PI3-K and rac stimulate cortical actin polymerization in COS-7SH cells and LY294002 can block this eect, LY294002 has no eect on the ruing caused by constitutively active rac (Ma et al., 1998) . A lipid product of PI3-K, phosphatidylinositol 3,4,5-triphosphate (PIP 3 ) binds rac and stimulates GDP dissociation (Missy et al., 1998) . Thus PI3-K represents a plausible link between IGF-I and the regulators of actin cytoskeletal dynamics that are important for the morphological changes associated with motility. Yet, inhibiting PI-3K alone had no eect on lamellipodium size in our experiments. While traditional models of cell motility hold that lamellipodium protrusion is required for translocation, there is some evidence to suggest that motility can occur independent of lamellipodia. Walker carcinosarcoma cells that were treated with the actin-sequestering toxin latrunculin A lost lamellipodia, and yet showed increased speed of translocation compared to controls with lamellipodia (Keller, 2000) . Thus it remains possible that translocation and lamellipodium elaboration are distinct events with dierent regulatory mechanisms.
Blocking the MAPK pathway with PD98059, an inhibitor of MEK, also attenuates IGF-I-mediated motility, albeit to a lesser degree than when PI3-K is blocked. A similar partial dependence on the integrity of MAPK signaling was observed with IGF-I-stimulated smooth muscle cell motility (Imai and Clemmons, 1999) . Considering that both the PI3-K and MAPK pathways need to be blocked in order to suppress lamellipodium enlargement, it is possible signaling targets of MAPK play some role in the motility process. Blocking both pathways simultaneously does not cause inhibition of motility greater than using LY294002 alone. This would suggest that the two pathways are not activating distinctly separate downstream targets. We have reported that blocking PI3-K inhibits activation of MAPK by IGF-I (Kim et al., 1998b) , so it is plausible that there is cross talk between the two pathways in motility signaling. As neither inhibitor completely suppresses IGF-I mediated motility, other pathways activated by IGF-I, including protein kinase C (FagerstroÈ m et al., 1996) and STATs (Zong et al., 2000) may be involved in regulating the motility response.
SH-SY5Y and SHEP cells, a less invasive NBL clone (Biedler et al., 1988) , dier in their utilization of IRS isoforms. Yee and colleagues (Jackson et al., 1999) have reported that breast cancer cells that speci®cally express the IRS-2 isoform show increased migration in response to IGF-I. We ®nd that SH-SY5Y cells only phosphorylate IRS-2, whereas SHEP/IGF-IR transfected cells phosphorylate IRS-1 (and very little IRS-2) in response to IGF-I (Figure 5a ). Only IRS-2 recruits the p85 subunit of PI3-K in SH-SY5Y cells upon IGF-I stimulation. In SHEP cells, only IRS-1 is able to recruit p85. Thus, the two cell lines exclusively utilize dierent IRS isoforms to activate PI3-K. SHEP cells do show less baseline motility than the IRS-2-expressing SH-SY5Y cells. Yet, the relative increase in motility caused by IGF-I in both cell lines is equivalent (Figure 5b ), suggesting that either IRS isoform is equally suited for transducing the signal from the IGF-IR to PI3-K that leads to increased cell motility. Alternatively, another IRS isoform may be speci®c for motility responses and expressed by both cell lines, accounting for their similar responsiveness to IGF-I.
In summary, IGF-I rapidly promotes a motile morphology in neuroblastoma cells by increasing the amount of dynamic morphological changes exhibited by the cells, culminating in the formation of large lamellipodia. The morphological changes depend upon the activation of the IGF-IR. Lamellipodium formation is linked to both PI3-K and MAPK signaling. These changes in morphology precede a long-term increase in the motility of the cells that depends largely upon the ability of PI3-K to activate downstream eectors, with some additional dependence on MAPKactivated eectors. IGF-I increases the motility of both highly invasive and less invasive NBL cell lines to a similar relative degree, but the absolute amount of motility exhibited by the two cells lines in response to IGF-I remains consistent with their in vivo invasion characteristics. IGF-I sitmulation of NBL cell motility may represent a mechanism whereby NBL cancer cells are stimulated to massively invade certain IGF-rich tissues such as bone.
Materials and methods
Reagents and antibodies
The anti-IGF-IR antibody (aIR-3) was purchased from Calbiochem Corporation (La Jolla, CA, USA), PD98059 from BioMol (Plymouth Crossing, PA, USA) and Sigma Chemical Co. (St. Louis, MO, USA). IGF-I was a gift of Cephalon Corporation (West Chester, PA, USA). Dulbecco's modi®ed Eagle's medium (DMEM) with high glucose, Lglutamine, and 110 mg/ml sodium pyruvate was from Life Technologies, Inc., and was pH buered with 3.7% sodium bicarbonate or 18 mM HEPES. Calf serum was purchased from HyClone (Logan, UT, USA), G418 antibiotic from Gibco BRL (Grand Island, NY, USA), and anti-phosphotyrosine antibodies from Transduction Laboratory (PY20; Lexington, KY, USA) and Upstate Biochemicals, Inc. (4G10; Lake Placid, NY, USA). Anti-IRS-1, anti-IRS-2, and anti-p85 pan antiserums were gifts from Dr MF White (Harvard Medical School). Horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit IgG and agaroseconjugated protein A/G-PLUS were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Enhanced chemiluminescence reagents were from Amersham Corp. (Arlington Heights, IL, USA).
Cells
Human SH-SY5Y and SHEP NBL cells were cultured in DMEM with 10% calf serum and maintained in a humidi®ed incubator with 10% CO 2 at 378C. SHEP cells transfected with the IGF-IR (described previously (Singleton et al., 1996) ) were maintained in DMEM+10% calf serum containing 400 mM G418. Wild type PTEN in the viral vector pTP2000 was provided by Dr Jack Dixon, University of Michigan. SHEP cells are infected with viral vector in the presence of polybrene for 24 h before selection in 500 mg/ml G418 for 2 weeks.
Video shape change assays SH-SY5Y cells were plated on 30 mm tissue-culture plastic dishes in DMEM+10% calf serum. After 24 h, media was replaced with serum-free HEPES-buered DMEM, and the cultures were incubated without additional CO 2 overnight. Cultures were placed on the heated stage of a Zeiss Axiovert 135 TV inverted microscope. Phase-contrast images of a single group of cells at 2006magni®cation were collected at 30 or 60 s intervals for 20 min, using a Panasonic monochrome CCD camera and NIH Image 1.61 software. Then, the cells were stimulated with 1 nM IGF-I and image collection of the same group of cells continued for another 20 ± 40 min. The images were compiled sequentially into a stack, and then subjected to dierence image analysis using customized macro command sets for NIH Image as previously described (Shelden and Feldman, 2000) . The area of a single cell's shape that changed between sequential images was measured by digitally subtracting each image from the previous image.
Measurement of lamellipodia
SH-SY5Y cells were plated on glass coverslips. When 40% con¯uent, cells were serum starved and treated with or without 10 mM PD98059 or LY294002 for 45 min. The cells were then treated with 1 nM IGF-I for 10 min, or left untreated. Cells were ®xed with 4% paraformaldehyde.
Images of cells were digitally collected with a 4061.4 NA objective using dierential interference contrast optics. The areas of all lamellipodia in randomly selected ®elds were measured using NIH Image. Experiments were repeated three times.
Measurement of cell motility
Cells were plated on gold particle-coated coverslips (prepared as described (Albrecht-Buehler, 1977) ) at a density of 25 000 cells per coverslip. The cells were incubated for 2 h to allow adhesion to the coverslip. Then, wells were treated with or without IGF-I. Incubation continued for 6 or 12 h, followed by ®xation with 3.5% glutaraldehyde. Coverslips were mounted on glass slides, then viewed on a Lietz Orthoplan inverted microscope attached to a Sony videoprocessor. Digital images of the tracks etched into the gold by the cells from three separately treated coverslips per condition were collected at 2006magni®cation using Adobe Photoshop 4.0 software. For each condition, the areas of 50 to 200 tracks made by individual cells were measured with NIH Image 1.61 software.
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were performed as described previously (Kim et al., 1998a) . After IGF-I stimulation, equal amounts of cell lysates were immunoprecipitated with either anti-IRS1 or anti-IRS2 antiserums followed by anti-phosphotyrosine or anti-p85 pan immunoblotting. Immunoreactive proteins were identi®ed by HRPconjugated secondary antibody followed by ECL reagents.
